These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35818184)

  • 1. Evaluating the effect of methotrexate on the rate of renal fibrosis by elastography and fibrosis-related gene expression.
    Wang Z; Ab Hamid S; Jiang Y; Shang X; Fu Z; Zhao Q; Ab Hamid S
    Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(6):291-297. PubMed ID: 35818184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of liver fibrosis by transient elastography in rheumatoid arthritis patients treated with methotrexate.
    Park SH; Choe JY; Kim SK
    Joint Bone Spine; 2010 Dec; 77(6):588-92. PubMed ID: 20471892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography.
    Erre GL; Cadoni ML; Meloni P; Castagna F; Mangoni AA; Piga M; Passiu G; Carru C; Zinellu A; Vidili G
    Eur J Intern Med; 2019 Nov; 69():57-63. PubMed ID: 31474422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Substantial Liver Fibrosis by Real-time Shear Wave Elastography in Methotrexate-Treated Patients With Rheumatoid Arthritis.
    Kim TY; Kim JY; Sohn JH; Lee HS; Bang SY; Kim Y; Kim MY; Jeong WK
    J Ultrasound Med; 2015 Sep; 34(9):1621-30. PubMed ID: 26269292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study).
    Feuchtenberger M; Kraus L; Nigg A; Schulze-Koops H; Schäfer A
    Rheumatol Int; 2021 Jun; 41(6):1079-1087. PubMed ID: 33608744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between Cumulative Methotrexate Dose, Metabolic Syndrome and Hepatic Fibrosis Detected by FibroScan in Rheumatoid Arthritis Patients.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S; Jatuworapruk K
    Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374233
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis.
    Arena U; Stasi C; Mannoni A; Benucci M; Maddali-Bongi S; Cammelli D; Assarat A; Marra F; Pinzani M
    Dig Liver Dis; 2012 Feb; 44(2):149-53. PubMed ID: 21930442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate.
    Lee SW; Park HJ; Kim BK; Han KH; Lee SK; Kim SU; Park YB
    Arthritis Res Ther; 2012 Oct; 14(5):R232. PubMed ID: 23107811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.
    Frankowski M; Świerkot J; Gomułkiewicz M; Korman L; Skoczyńska M; Starba A
    Rheumatol Int; 2022 Apr; 42(4):631-638. PubMed ID: 34870735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound liver elastography for the detection of liver fibrosis in patients with psoriasis and reactive arthritis on long-term methotrexate therapy: A cross-sectional study.
    Khandpur S; Yadav D; Jangid B; Kumar A; Shalimar ; Devasenathipathy K; Sharma R; Gupta SD; Kumar R; Kalaivani M
    Indian J Dermatol Venereol Leprol; 2020; 86(5):508-514. PubMed ID: 32525101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate: Utility of fibroscan and biochemical markers in routine clinical practice.
    de Diego-Sola A; Castiella Eguzkiza A; López Domínguez LM; Urreta Barallobre I; Sánchez Iturri MJ; Belzunegui Otaño JM; Zapata Morcillo EM;
    Reumatol Clin (Engl Ed); 2023 Oct; 19(8):412-416. PubMed ID: 37805254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of liver fibrosis markers in people with rheumatoid arthritis on methotrexate.
    Olsson-White DA; Olynyk JK; Ayonrinde OT; Paramalingam S; Keen HI
    Intern Med J; 2022 Apr; 52(4):566-573. PubMed ID: 33135387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis.
    Bafna P; Sahoo RR; Hazarika K; Manoj M; Rungta S; Wakhlu A
    Clin Rheumatol; 2021 Sep; 40(9):3605-3613. PubMed ID: 33686476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of liver elasticity with shear-wave elastography in juvenile idiopathic arthritis patients receiving methotrexate.
    Özdemir Çiçek S; Karaman ZF; Şahin N; Paç Kısaarslan A; Poyrazoğlu MH; Düşünsel R
    Pediatr Int; 2022 Jan; 64(1):e15239. PubMed ID: 36217648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate.
    Hilal G; Akasbi N; Boudouaya H; Salma K; Harzy T
    Curr Rheumatol Rev; 2020; 16(4):293-297. PubMed ID: 32189595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associated factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate.
    Slouma M; Lahmar W; Mohamed G; Dhrif O; Dhahri R; Bellali H; Gharsallah I; Ebdelli N
    Clin Rheumatol; 2024 Mar; 43(3):929-938. PubMed ID: 38159207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated.
    Atallah E; Grove JI; Crooks C; Burden-Teh E; Abhishek A; Moreea S; Jordan KM; Ala A; Hutchinson D; Aspinall RJ; Murphy R; Aithal GP
    J Hepatol; 2023 May; 78(5):989-997. PubMed ID: 36702175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function.
    Park JS; Park MC; Park YB; Lee SK; Lee SW
    Clin Rheumatol; 2014; 33(10):1415-23. PubMed ID: 24941927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using FibroScan to Assess for the Development of Liver Fibrosis in Patients With Arthritis on Methotrexate: A Single-center Experience.
    Darabian S; Wade JP; Kur J; Wade SD; Sayre EC; Badii M
    J Rheumatol; 2022 Jun; 49(6):558-565. PubMed ID: 35293340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.